Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib
Clinical trial NCT02398825 · TERMINATED
Trial details
- NCT number
- NCT02398825
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-23
- Primary completion
- 2020-11-13
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.